IDEX Corporation’s IEX first-quarter 2025 adjusted earnings of $1.75 per share surpassed the Zacks Consensus Estimate of $1.64. The bottom line decreased 7% from the year-ago quarter’s earnings of $1.88 per share. Management projected adjusted earnings to be in the band of $1.18-$1.24 per share in the quarter. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) IEX’s Revenue Details IDEX’s net sales of $814.3 million beat the Zacks Consensus Estimate of $811 million. The top line increased 2% year over year. Organic sales decreased 1% year over year. Acquisitions/divestitures had a positive impact on sales of 4%, while foreign currency translation had a negative impact of 1% on sales. IEX reports net sales under three business segments, the results of which are discussed below: Net sales from the Fluid & Metering Technologies segment totaled $290.5 million, down 7% year over year. Our estimate for segmental net sales was $293.6 million. Organic sales decreased 4% year over year. Acquisition/divestitures impacted sales by 2%, while foreign currency translation had a negative impact of 1% on sales. Net sales from the Health & Science Technologies segment totaled $341.5 million, up 10% year over year. Our estimate for segmental net sales was $332.9 million. Organic sales declined 1% year over year. Acquisitions/divestitures had a positive impact on sales of 12%, while foreign currency translation had a negative impact of 1% on sales. Net sales from the Fire & Safety/Diversified Products segment totaled $184.3 million, which increased 4% year over year. Our estimate for segmental net sales was $177.6 million. Organic sales increased 5% on a year-over-year basis, while foreign currency translation had a negative impact of 1% on sales. IDEX Corporation Price, Consensus and EPS Surprise IDEX Corporation price-consensus-eps-surprise-chart | IDEX Corporation Quote IDEX’s Margin Profile IDEX’s cost of sales increased 0.5% year over year to $445.4 million. The gross profit was $368.9 million, up 3.2% year over year. The gross margin was 45.3% compared with 44.6% in the year-ago quarter. Selling, general and administrative expenses increased 7.3% year over year to $209.4 million. Adjusted EBITDA was $208.0 million, almost in line with the year-ago quarter. The adjusted EBITDA margin decreased 50 bps year over year to 25.5%. The operating income was $142.0 million, down 11.9% year over year. The operating margin was 17.4%, down 270 bps year over year. Interest expenses (net) increased 72.3% year over year to $16.1 million. Story Continues Balance Sheet and Cash Flow of IDEX While exiting the first quarter, IDEX’s cash and cash equivalents were $594.1 million compared with $620.8 million at the end of fourth-quarter 2024. Long-term borrowings (net) were $1.84 billion compared with $1.9 billion at the end of fourth-quarter 2024. In the first quarter of 2025, IDEX generated net cash of $105.7 million from operating activities, down 32.5% from the year-ago period. Capital expenditures were $14.3 million compared with $20 million in first-quarter 2024. In the same period, free cash flow was $91.4 million, down 33.1% year over year. IDEX paid out dividends totaling $52.4 million in the first three months of 2025, up 8% year over year. IDEX’s Outlook For the second quarter, IDEX anticipates adjusted earnings to be in the band of $1.95 - $2.05 per share. On a GAAP basis, IEX predicts earnings to be in the range of $1.60 - $1.72 per share. It expects organic sales to increase in the range of 0-2% from the year-ago reading. For 2025, the company has reaffirmed its guidance. IDEX anticipates adjusted earnings to be in the band of $8.10-$8.45 per share. The figure indicates an increase from earnings of $7.89 per share reported in 2024. On a GAAP basis, earnings are predicted to be in the band of $6.56-$6.96 per share. Organic sales are predicted to increase in the range of 1-3%. IEX’s Zacks Rank The company currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Performance of Other Companies AZZ Inc. AZZ came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.95. This compares with earnings of $0.93 per share a year ago. AZZ reported revenues of $351.88 million, missing the consensus estimate by 3.77%. This compares with year-ago revenues of $366.5 million. Valmont Industries VMI reported revenues of $969.31 million in the first quarter of 2025, declining 0.9% on a year-over-year basis. Earnings per share of $4.32 for the same period compare with $4.32 a year ago. The reported revenues compare with the Zacks Consensus Estimate of $975.6 million. The company delivered an earnings surprise of 1.89%, with the consensus estimate being $4.24 per share. Pentair plc PNR came out with quarterly earnings of $1.11 per share in the first quarter of 2025, beating the Zacks Consensus Estimate of $1.01. This compares with earnings of $0.94 per share a year ago. Pentair posted revenues of $1.01 billion for the quarter, surpassing the consensus estimate by 2.68%. This compares with year-ago revenues of $1.02 billion. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Valmont Industries, Inc. (VMI):Free Stock Analysis Report AZZ Inc. (AZZ):Free Stock Analysis Report IDEX Corporation (IEX):Free Stock Analysis Report Pentair plc (PNR):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
IDEX Q1 Earnings Surpass Estimates, Sales Increase Year Over Year
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...